CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,152 | -46.7% | 33,894 | -43.5% | 0.06% | -39.6% |
| Q1 2023 | $2,160 | -33.0% | 60,008 | -17.0% | 0.10% | -38.1% |
| Q4 2022 | $3,226 | -99.8% | 72,336 | -0.8% | 0.16% | +56.6% |
| Q3 2022 | $2,051,000 | +364.0% | 72,919 | +344.6% | 0.10% | +421.1% |
| Q2 2022 | $442,000 | -20.9% | 16,400 | 0.0% | 0.02% | -13.6% |
| Q1 2022 | $559,000 | -22.6% | 16,400 | -12.3% | 0.02% | 0.0% |
| Q4 2021 | $722,000 | -59.8% | 18,700 | -43.8% | 0.02% | -62.1% |
| Q3 2021 | $1,798,000 | +60.5% | 33,300 | -0.6% | 0.06% | +56.8% |
| Q2 2021 | $1,120,000 | – | 33,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |